CM Life Sciences II Inc. Unit
CMIIU
CMIIU was delisted on the 1st of September, 2021.
58 hedge funds and large institutions have $290M invested in CM Life Sciences II Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$34.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$15.7M |
| 4 |
PA
Perceptive Advisors
New York
|
+$15.7M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$13M |
Top Sellers
CMIIU Hedge Fund Activity: Q1 2021 in Review
58 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q1 2021, worth a combined $290M.
Buyers outnumbered sellers: 58 funds opened new CMIIU positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SB Management, opening a new position worth an estimated $34.3M.
- 58 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $290M of CM Life Sciences II Inc. Unit stock for Q1 2021.
- 58 funds opened new CM Life Sciences II Inc. Unit positions in Q1 2021 and 0 closed out, a net change of +58 holders.
- The largest CM Life Sciences II Inc. Unit buyer in Q1 2021 was SB Management, an estimated $34.3M added.
Based on aggregated 13F filings for Q1 2021.